Is the UK really neglecting a clean source of energy? Before throwing money into fuel cells, potential investors might like to ask where the energy comes from.
The Department of Trade and Industry has set out a new set of priorities for its investment in R&D. The usual mixed bag, with a nod towards climate change.
Blue biotech is getting into its stride, as the tools of genomics and high throughput screening are applied to unlock the chemical diversity of the oceans.
Biotech start-ups in France and elsewhere in Europe make a unique and important contribution to healthcare. They merit special treatment to help them grow.
The European Commission adopted new rules for investing public money in small private companies that it says will make it easier for start-ups to raise risk capital.
The UK government said it will contribute £16 million to a £32 million programme aimed at ensuring the safe operation of unmanned aviation vehicles (UAV) in civil airspace.
An interesting set of deals bring together major companies and the Engineering and Physical Sciences Research Council in a new model for academic/industry collaboration.
PharmaLinks, a business dedicated to commercialising pharmaceutical research, is looking for a development partner for an immunosuppressive cytokine with therapeutic potential in inflammatory diseases including rheumatoid arthritis, asthma, COPD and arteriosclerosis.
It is a hard life being an electronics business, they just keep changing the science under you. This time around we have a combination of electronics and spin – and that has nothing to do with PR.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.